PHARMA SIGNALOPEN RESEARCH PLATFORM →
COMPANY RESEARCH PROFILE · UPDATED 2026-09-29

Roche

Global pharma company known for oncology and immunology medicines and significant biologics expertise.

TICKERROG
HEADQUARTERSBasel, Switzerland
STAGEApproved
ACTIVE TRIALS203

Therapeutic areas

Oncologyimmunologyneuroscience

Selected products and programs

OcrevusTecentriqAvastin

Linked curated drug profiles

emicizumab

Bispecific monoclonal antibody

satralizumab

IL-6 receptor-directed monoclonal antibody

tocilizumab

IL-6 receptor-directed monoclonal antibody

Selected active clinical trials

A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy

Phase 3 · Recruiting · Breast Cancer

A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast Cancer

Phase 3 · Recruiting · Metastatic Breast Cancer

A Study to Assess the Efficacy and Safety of Induction Therapy With Afimkibart (Also Known as RO7790121) in Participants With Moderately to Severely Active Ulcerative Colitis

Phase 3 · Recruiting · Moderately to Severely Active Ulcerative Colitis

A Study To Evaluate Pharmacokinetics, Efficacy, Safety, Tolerability, And Pharmacodynamics Of Satralizumab In Pediatric Patients With Aquaporin-4 Antibody Positive Neuromyelitis Optica Spectrum Disorder (NMOSD)

Phase 3 · Recruiting · Neuromyelitis Optica Spectrum Disorder

A Study to Assess the Efficacy and Safety of Emicizumab in Participants With Type 3 Von Willebrand Disease

Phase 3 · Recruiting · Von Willebrand Disease, Type 3

A Surveillance Study of Susceptibility to Baloxavir Marboxil in Pediatric Participants With Influenza and Transmission of Influenza to Household Contacts

Phase 3 · Recruiting · Influenza

Selected patent records

No linked FDA Orange Book patent record was found for the selected products.

Primary and company sources

Company and pipeline information can change. Verify material decisions against the linked primary sources.

Evidence & limits

Source: Open the source record

Record identifier
/companies/roche/
Event / action date
Not separately retained
Source update date
Not separately retained
Platform retrieval / processing date
Not separately retained

What it supports. Connections found through the catalog, identifiers, or name and alias matching, with source links where retained.

Limits. A company association is not proof of ownership or sponsorship of every linked record. Product, substance, parent-company, and subsidiary relationships may differ.

Connection basis. Catalog, identifier, or normalized name association. Product and company connections are research leads, not ownership determinations.

What this record means · Report an issue with this record